Consolidated Statement Of Income

BrightPath Biotherapeutics Co., Ltd. - Filing #7576995

Concept 2022-04-01 to
2022-12-31
2021-04-01 to
2021-12-31
Consolidated statement of income
Statement of income
Net sales
5,229,000 JPY
330,000 JPY
Cost of sales
1,282,000 JPY
82,000 JPY
Operating expenses
Selling, general and administrative expenses
1,222,318,000 JPY
1,073,965,000 JPY
Operating expenses
Ordinary profit (loss)
-1,223,957,000 JPY
-1,076,020,000 JPY
Operating profit (loss)
-1,218,371,000 JPY
-1,073,717,000 JPY
Gross profit (loss)
3,946,000 JPY
247,000 JPY
Net sales
Cost of sales
Selling, general and administrative expenses
Non-operating income
Interest income
11,000 JPY
14,000 JPY
Other
546,000 JPY
89,000 JPY
Non-operating income
557,000 JPY
103,000 JPY
Extraordinary income
JPY
4,468,000 JPY
Extraordinary losses
JPY
5,301,000 JPY
Impairment losses
JPY
5,264,000 JPY
Non-operating expenses
6,144,000 JPY
2,407,000 JPY
Share issuance costs
2,064,000 JPY
1,430,000 JPY
Non-operating expenses
Other
61,000 JPY
JPY
Profit (loss) before income taxes
-1,223,957,000 JPY
-1,076,854,000 JPY
Gross profit
Extraordinary income
Gain on sale of non-current assets
JPY
13,000 JPY
Income taxes - current
1,425,000 JPY
1,815,000 JPY
Extraordinary losses
Loss on retirement of non-current assets
JPY
37,000 JPY
Income taxes
1,425,000 JPY
1,815,000 JPY
Profit (loss)
-1,225,382,000 JPY
-1,078,669,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.